Having lost a challenge to privatisation agreements by NSW Ports, the competition regulator wants to intervene in a High Court appeal by Mayfield Developments, which failed in its own case against the port authority.
Infrastructure giant Acciona must fight a $224M lost-revenue case by contractor Veolia Australia over the Kwinana waste-to-energy plant on Veolia’s home turf.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
The High Court has been asked to clarify the extent to which computer-implemented ideas are eligible for patent protection, with IP Australia appealing a win for gaming giant Aristocrat.
The competition regulator is seeking to intervene in Mayfield Development’s appeal to the High Court in a case the developer says could have “startling” consequences.
In the first-ever civil penalty proceedings for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has been ordered to pay $5.8 million over a 2022 data breach that compromised the sensitive personal information of 223,000 customers of its Medlab business.
Green iron startup Element Zero is challenging a bid by Fortescue for access to nine million seized documents in their trade secrets spat, saying its rival has not met the test for proving inadequate discovery of material.
Mayfield Developments has argued the High Court should overturn a finding that NSW Ports was protected by derivative Crown immunity in entering allegedly uncompetitive agreements to privatise two ports, saying the decision could have “startling” consequences such as allowing the state to devise cartel arrangements.
In the first penalty to be handed down for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has agreed to cop a $5.8 million fine over a 2022 data breach that compromised the personal information of 223,000 customers of its Medlab business.
Hall & Wilcox has struck back at proceedings by the liquidators for collapsed construction group Hastie, saying they have failed to specify why its $18.6 million legal bill incurred in suing two dozen builders is unreasonable.